Please enable JavaScript to continue using this application.

Compare $CRBP vs $OKUR | Chartloom

Compare

$CRBP vs $OKUR

Corbus Pharmaceuticals Holdings Inc · Onkure Therapeutics Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

OKUR

Onkure Therapeutics Inc

Compare $CRBP vs $OKUR

Comparing Corbus Pharmaceuticals Holdings Inc and Onkure Therapeutics Inc

CRBPCorbus Pharmaceuticals Holdings Inc

OKUROnkure Therapeutics Inc

CRBPCorbus Pharmaceuticals Holdings Inc

Market cap

$100M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-31.6%

52W performance

-59.9%

FCF yield

-87.0%

OKUROnkure Therapeutics Inc

Market cap

$97M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

71.59x

Rev growth (TTM)

—

YTD performance

-18.6%

52W performance

-20.7%

FCF yield

-49.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBP

OKUR

Detailed metrics comparison

CRBP

Corbus Pharmaceuticals Holdings Inc

OKUR

Onkure Therapeutics Inc

Market Cap

CRBP$100M

OKUR$97M

Enterprise Value

CRBP$76M

OKUR$-69M

Price

CRBP$5.38

OKUR$2.41

P/E Ratio

CRBPN/A

OKURN/A

P/S Ratio

CRBP76.49x

OKUR0.00x

EV/Sales

CRBP61.41x

OKUR0.00x

EV/EBITDA

CRBP0.00x

OKUR0.00x

P/B Ratio

CRBP1.16x

OKUR0.60x

P/FCF Ratio

CRBPN/A

OKURN/A

EV/FCF

CRBP-0.88x

OKUR1.44x

PEG Ratio

CRBPN/A

OKURN/A

Forward P/E (NTM)

CRBPN/A

OKURN/A

Forward P/S (NTM)

CRBPN/A

OKUR71.59x

Revenue (TTM)

CRBP$0

OKUR$0

Revenue Growth (YoY)

CRBPN/A

OKURN/A

Forward Rev Growth

CRBP116.0%

OKUR100.0%

Gross Margin (TTM)

CRBP0.0%

OKUR0.0%

Operating Margin (TTM)

CRBP0.0%

OKUR0.0%

EBITDA Margin (TTM)

CRBP0.0%

OKUR0.0%

Net Margin (TTM)

CRBP0.0%

OKUR0.0%

FCF Margin (TTM)

CRBPN/A

OKURN/A

Net Income (TTM)

CRBP$-102M

OKUR$-59M

FCF (TTM)

CRBP$-87M

OKUR$-48M

EPS (TTM)

CRBP-$5.25

OKUR-$1.18

ROE (TTM)

CRBP-8705.0%

OKUR-4902.0%

ROA (TTM)

CRBP-7422.0%

OKUR-4577.0%

ROIC (TTM)

CRBP-8705.0%

OKUR-4902.0%

Cash

CRBP$23M

OKUR$167M

Debt

CRBP$0

OKUR$0

Net Cash/Debt

CRBP$23M

OKUR$167M

Current Ratio (TTM)

CRBP5.71x

OKUR26.75x

Quick Ratio (TTM)

CRBP5.62x

OKUR26.55x

Debt/Equity (TTM)

CRBP0.00x

OKUR0.00x

Debt/Assets (TTM)

CRBP0.0%

OKUR0.0%

Interest Coverage (TTM)

CRBPN/A

OKURN/A

Net Debt/EBITDA (TTM)

CRBP0.00x

OKUR0.00x

Beta

CRBP2.74

OKUR0.19

52W Performance

CRBP-59.9%

OKUR-20.7%

YTD Performance

CRBP-31.6%

OKUR-18.6%

% from 52W High

CRBP-73.8%

OKUR-55.2%

% from 52W Low

CRBP4.9%

OKUR13.1%

Asset Turnover (TTM)

CRBP0.01x

OKUR0.00x

FCF Yield (TTM)

CRBP-87.0%

OKUR-49.2%

Earnings Yield (TTM)

CRBP-102.2%

OKUR-60.3%

Dividend Yield (TTM)

CRBPN/A

OKURN/A

Rule of 40

CRBP0.0

OKUR0.0

EV/GP/RG

CRBPN/A

OKURN/A

Ticker research

View CRBP research View OKUR research

Metric	CRBP Corbus Pharmaceuticals Holdings Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$100M	$97M
Enterprise Value	$76M	$-69M
Price	$5.38	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	76.49x	0.00x
EV/Sales	61.41x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.16x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.88x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	116.0%	100.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-102M	$-59M
FCF (TTM)	$-87M	$-48M
EPS (TTM)	-$5.25	-$1.18
ROE (TTM)	-8705.0%	-4902.0%
ROA (TTM)	-7422.0%	-4577.0%
ROIC (TTM)	-8705.0%	-4902.0%
Financial Health
Cash	$23M	$167M
Debt	$0	$0
Net Cash/Debt	$23M	$167M
Current Ratio (TTM)	5.71x	26.75x
Quick Ratio (TTM)	5.62x	26.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.74	0.19
52W Performance	-59.9%	-20.7%
YTD Performance	-31.6%	-18.6%
% from 52W High	-73.8%	-55.2%
% from 52W Low	4.9%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-87.0%	-49.2%
Earnings Yield (TTM)	-102.2%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBP research	View OKUR research

Valuation

P/S Ratio

OKUR

0.00x

CRBP

76.49x

EV/FCF

CRBP

-0.88x

OKUR

1.44x

Growth & revenue

Forward Revenue Growth

CRBP

116.0%

OKUR

100.0%

Profitability & performance

Gross Margin

CRBP

0.0%

OKUR

0.0%

ROE

OKUR

-4902.0%

CRBP

-8705.0%

FCF Yield %

OKUR

-49.2%

CRBP

-87.0%

52-Week Performance

OKUR

-20.7%

CRBP

-59.9%

Detailed metrics comparison

CRBP

Corbus Pharmaceuticals Holdings Inc

OKUR

Onkure Therapeutics Inc

Market Cap

CRBP$100M

OKUR$97M

Enterprise Value

CRBP$76M

OKUR$-69M

Price

CRBP$5.38

OKUR$2.41

P/E Ratio

CRBPN/A

OKURN/A

P/S Ratio

CRBP76.49x

OKUR0.00x

EV/Sales

CRBP61.41x

OKUR0.00x

EV/EBITDA

CRBP0.00x

OKUR0.00x

P/B Ratio

CRBP1.16x

OKUR0.60x

P/FCF Ratio

CRBPN/A

OKURN/A

EV/FCF

CRBP-0.88x

OKUR1.44x

PEG Ratio

CRBPN/A

OKURN/A

Forward P/E (NTM)

CRBPN/A

OKURN/A

Forward P/S (NTM)

CRBPN/A

OKUR71.59x

Revenue (TTM)

CRBP$0

OKUR$0

Revenue Growth (YoY)

CRBPN/A

OKURN/A

Forward Rev Growth

CRBP116.0%

OKUR100.0%

Gross Margin (TTM)

CRBP0.0%

OKUR0.0%

Operating Margin (TTM)

CRBP0.0%

OKUR0.0%

EBITDA Margin (TTM)

CRBP0.0%

OKUR0.0%

Net Margin (TTM)

CRBP0.0%

OKUR0.0%

FCF Margin (TTM)

CRBPN/A

OKURN/A

Net Income (TTM)

CRBP$-102M

OKUR$-59M

FCF (TTM)

CRBP$-87M

OKUR$-48M

EPS (TTM)

CRBP-$5.25

OKUR-$1.18

ROE (TTM)

CRBP-8705.0%

OKUR-4902.0%

ROA (TTM)

CRBP-7422.0%

OKUR-4577.0%

ROIC (TTM)

CRBP-8705.0%

OKUR-4902.0%

Cash

CRBP$23M

OKUR$167M

Debt

CRBP$0

OKUR$0

Net Cash/Debt

CRBP$23M

OKUR$167M

Current Ratio (TTM)

CRBP5.71x

OKUR26.75x

Quick Ratio (TTM)

CRBP5.62x

OKUR26.55x

Debt/Equity (TTM)

CRBP0.00x

OKUR0.00x

Debt/Assets (TTM)

CRBP0.0%

OKUR0.0%

Interest Coverage (TTM)

CRBPN/A

OKURN/A

Net Debt/EBITDA (TTM)

CRBP0.00x

OKUR0.00x

Beta

CRBP2.74

OKUR0.19

52W Performance

CRBP-59.9%

OKUR-20.7%

YTD Performance

CRBP-31.6%

OKUR-18.6%

% from 52W High

CRBP-73.8%

OKUR-55.2%

% from 52W Low

CRBP4.9%

OKUR13.1%

Asset Turnover (TTM)

CRBP0.01x

OKUR0.00x

FCF Yield (TTM)

CRBP-87.0%

OKUR-49.2%

Earnings Yield (TTM)

CRBP-102.2%

OKUR-60.3%

Dividend Yield (TTM)

CRBPN/A

OKURN/A

Rule of 40

CRBP0.0

OKUR0.0

EV/GP/RG

CRBPN/A

OKURN/A

Ticker research

View CRBP research View OKUR research

Metric	CRBP Corbus Pharmaceuticals Holdings Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$100M	$97M
Enterprise Value	$76M	$-69M
Price	$5.38	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	76.49x	0.00x
EV/Sales	61.41x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.16x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.88x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	116.0%	100.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-102M	$-59M
FCF (TTM)	$-87M	$-48M
EPS (TTM)	-$5.25	-$1.18
ROE (TTM)	-8705.0%	-4902.0%
ROA (TTM)	-7422.0%	-4577.0%
ROIC (TTM)	-8705.0%	-4902.0%
Financial Health
Cash	$23M	$167M
Debt	$0	$0
Net Cash/Debt	$23M	$167M
Current Ratio (TTM)	5.71x	26.75x
Quick Ratio (TTM)	5.62x	26.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.74	0.19
52W Performance	-59.9%	-20.7%
YTD Performance	-31.6%	-18.6%
% from 52W High	-73.8%	-55.2%
% from 52W Low	4.9%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-87.0%	-49.2%
Earnings Yield (TTM)	-102.2%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBP research	View OKUR research